Buy Rating Affirmed for Quantum-Si on Strong Financials and Promising Product Pipeline
Analysts Offer Insights on Healthcare Companies: Quantum-Si (QSI), Savara (SVRA) and Ventyx Biosciences (VTYX)
Quantum-Si Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Quantum-Si, Maintains $4 Price Target
Analysts Offer Insights on Healthcare Companies: Privia Health Group (PRVA), Revance Therapeutics (RVNC) and Quantum-Si (QSI)
Quantum-Si: A Balanced Hold Rating Amidst Early-Stage Commercialization and Innovation
Quantum-Si Analyst Ratings
HC Wainwright & Co. Initiates Coverage On Quantum-Si With Buy Rating, Announces Price Target of $3
Quantum-Si Analyst Ratings
Hold Rating Maintained for Quantum-Si Amid Controlled Commercial Launch and Strategic Initiatives
Quantum-Si Analyst Ratings
Canaccord Genuity Downgrades Quantum-Si to Hold From Buy, Trims Price Target to $2 From $3.50